Michael A. Mussallem
Michael A. Mussallem is chairman and CEO of Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring. Driven by a passion to help patients, the company partners with clinicians to develop innovative technologies in the areas of structural heart disease and critical care monitoring that enable them to save and enhance lives.
Mr. Mussallem has been chairman and CEO since 2000, when the company was spun off from Baxter International. At Baxter, Mr. Mussallem held a variety of positions with increasing responsibility, in engineering, product development, and senior management, including group vice president of its cardiovascular business (1994 to 2000) and group vice president of the biopharmaceutical business (1998 to 2000). From 1996 until 1998, he was the chairman of Baxter's Asia board, overseeing Baxter's operations throughout Asia. Previously, he worked for Union Carbide.
Mr. Mussallem is the former chairman of the board of directors of the Advanced Medical Technology Association (AdvaMed). He is currently on the boards and executive committees of AdvaMed, California Healthcare Institute, and OCTANe, and is a trustee of the University of California, Irvine Foundation. Mr. Mussallem received a bachelor's degree in chemical engineering and an honorary doctorate degree from the Rose-Hulman Institute of Technology in Terre Haute, Indiana.